BPC-157 vs GHK-Cu vs TB-500 (Thymosin Beta-4 Fragment)
Updated July 29, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of BPC-157 and GHK-Cu and TB-500 (Thymosin Beta-4 Fragment) (also searched as TB-500 (Thymosin Beta-4 Fragment) vs GHK-Cu vs BPC-157) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
Comparing BPC-157, GHK-Cu, TB-500 (Thymosin Beta-4 Fragment) across AI-assigned effect profiles and indexed evidence. GHK-Cu has the most studies (10). Match each to your goal below, and read the primary research before deciding. Research information, not medical advice.
Key takeaways
- •BPC-157 is strongest for healing; GHK-Cu for skin.
- •Evidence: BPC-157 Human evidence (9 studies) vs GHK-Cu Preclinical (10).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
Body Protection Compound-157 | Pentadecapeptide
Copper Peptide | Skin Regeneration & Anti-Aging Compound
Synthetic Fragment (17-23) of Thymosin Beta-4
BPC-157 vs GHK-Cu vs TB-500 (Thymosin Beta-4 Fragment): side-by-side
| Metric | BPC-157 | GHK-Cu | TB-500 (Thymosin Beta-4 Fragment) |
|---|---|---|---|
| Class | Healing | Skin | Healing |
| Regulatory status | Research use only | Research use only | Research use only |
| Evidence grade | Human evidence | Preclinical | Preclinical |
| Studies indexed | 9 | 10 | 4 |
| Research level | Extensively Studied | Well Studied | Well Studied |
| Strongest effect | Healing & recovery | Skin & aesthetics | Healing & recovery |
| Healing & recovery | 4.0▲ | 4.0▲ | 4.0▲ |
| Muscle & body comp | 3.0▲ | 1.0 | 2.0 |
| Metabolic & appetite | 2.0▲ | 2.0▲ | 1.0 |
| Neuro & mood | 3.0▲ | 3.0▲ | 2.0 |
| Sleep & circadian | 1.0▲ | 1.0▲ | 1.0▲ |
| Inflammation & immune | 4.0▲ | 4.0▲ | 4.0▲ |
| Skin & aesthetics | 2.0 | 5.0▲ | 2.0 |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | BPC-157 | GHK-Cu | TB-500 (Thymosin Beta-4 Fragment) |
|---|---|---|---|
| Mechanism | Body-protective compound (pentadecapeptide); cytoprotective, pro-angiogenic signaling | Copper-binding tripeptide (GHK-Cu); tissue-remodeling / regenerative signaling | Actin-sequestering peptide; promotes cell migration & angiogenesis |
| Route | Subcutaneous / oral (research use) | Topical / subcutaneous | Subcutaneous injection (research use) |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is BPC-157?
Body Protective Compound often discussed for soft-tissue repair, GI support, and inflammation modulation.
Full BPC-157 profile, mechanism & studies →What is GHK-Cu?
Copper-binding tripeptide widely used in skin, hair, and wound-healing contexts, with systemic effects explored in research.
Full GHK-Cu profile, mechanism & studies →What is TB-500 (Thymosin Beta-4 Fragment)?
### Summary TB-500, a synthetic derivative of thymosin beta-4, is a peptide that has garnered attention for its potential role in tissue repair and regeneration. Research into TB-500 is ongoing, particularly regarding its applications in equine medicine and its implications in doping control.
Full TB-500 (Thymosin Beta-4 Fragment) profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Even | Both ~4.0/5 |
| Muscle | BPC-157 | 3.0/5 effect signal |
| Metabolic | Even | Both ~2.0/5 |
| Neuro | Even | Both ~3.0/5 |
| Sleep | Even | Both ~1.0/5 |
| Inflammation | Even | Both ~4.0/5 |
| Skin | GHK-Cu | 5.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack BPC-157 and GHK-Cu?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
BPC-157 vs GHK-Cu: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
BPC-157 has 9 approved studies indexed (Human evidence), and GHK-Cu has 10 (Preclinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is BPC-157 or GHK-Cu better?
It depends on your goal. BPC-157 is strongest for healing; GHK-Cu for skin. GHK-Cu has more indexed studies (10). See the goal-by-goal breakdown above.
Is BPC-157 or GHK-Cu better for weight loss?
They score similarly on the metabolic/appetite axis in the community data.
Is BPC-157 or GHK-Cu better for muscle?
BPC-157 leads on the muscle & body-composition axis (3.0/5).
Which has more research, BPC-157 or GHK-Cu?
BPC-157 has 9 approved studies indexed (Human evidence); GHK-Cu has 10 (Preclinical). Higher counts mean more to read, not proven superiority.
Can you stack BPC-157 and GHK-Cu?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of BPC-157 vs GHK-Cu?
BPC-157: no community-reported effects logged yet. GHK-Cu: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is BPC-157 or GHK-Cu FDA-approved?
BPC-157 is a research-use compound and is not FDA-approved. GHK-Cu is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is GHK-Cu better than BPC-157?
For skin, GHK-Cu has the edge; for healing, BPC-157 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
BPC-157 and GHK-Cu and TB-500 (Thymosin Beta-4 Fragment) are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 29, 2026.